Coronavirus in India: Infections cross five million mark

A record increase in coronavirus cases has been seen in India as the country crosses the five million mark.

The virus has invaded the country in less time. India has become the country having the second-highest number of infections in the world after the US. The US has crossed the six million mark. 

Also Read

Coronavirus: Oxford University vaccine trial paused as participant falls ill

Final clinical trials for the coronavirus vaccine, developed by Oxford University, were...

Daily cases are crossing 90,000 for the five days Until Monday. More than 80,000 people have died due to a shortage of care beds and oxygen supplies.

As per the latest updates, India has 5,020,359 confirmed cases of Covid-19 out of which 82,091 have died and 3,942,360 have recovered. The number of active cases is 995,908 in the country.

However, the government claimed that the death rate is much lower than in other countries.

Oxygen shortage

Oxygen demand has increased recently.

According to data obtained from All India Industrial Gases Manufacturers Association, Hospitals and care centers are consuming up to about 2,700 tonnes of oxygen every day this month, compared with 750 tonnes in April. 

The states including Maharashtra, Madhya Pradesh, Gujarat, Rajasthan, Telangana, Andhra Pradesh reported an increase in the cases.

Government lifts restrictions

Despite the surge in the cases, the Indian government continues to lift restrictions to strengthen the economy that lost many jobs. 

The virus hit the megacities including Mumbai and the capital Delhi after the lockdown restrictions were eased.

Oxford University vaccine trial paused as participant falls ill

Final clinical trials for the coronavirus vaccine, developed by Oxford University, were stopped as a participant had an adverse reaction in the UK.

According to details, coronavirus vaccines were developed byAstraZeneca and Oxford University in the UK. AstraZeneca called it a “routine” pause in the case of “an unexplained illness”.

Experts are closely watching the results of vaccine trials around the world.

According to the international news agency BBC, all international trial sites have now been put on hold whereas an independent investigation reviews the safety data before regulators decide whether the trial can restart.